When you include the American Institute for Cancer Research in your estate plans, you make a major difference in the fight against cancer.

Corporate Champions who partner with the American Institute for Cancer Research stand at the forefront of the fight against cancer

The Annual AICR Research Conference is the most authoritative source for information on diet, obesity, physical activity and cancer.

The Continuous Update Project (CUP) is an ongoing program that analyzes global research on how diet, nutrition and physical activity affect cancer risk and survival.

A major milestone in cancer research, the Third Expert Report analyzes and synthesizes the evidence gathered in CUP reports and serves as a vital resource for anyone interested in preventing cancer.

AICR has pushed research to new heights, and has helped thousands of communities better understand the intersection of lifestyle, nutrition, and cancer.

Read real-life accounts of how AICR is changing lives through cancer prevention and survivorship.

We bring a detailed policy framework to our advocacy efforts, and provide lawmakers with the scientific evidence they need to achieve our objectives.

AICR champions research that increases understanding of the relationship between nutrition, lifestyle, and cancer.

AICR’s resources can help you navigate questions about nutrition and lifestyle, and empower you to advocate for your health.

AICR is committed to putting what we know about cancer prevention into action. To help you live healthier, we’ve taken the latest research and made 10 Cancer Prevention Recommendations.

Government funding for cancer research

Due to investments in research through the National Cancer Institute, rates of new cancers are declining. While AICR has funded nearly $110 million for research in our own grant program, continued federal government investment in cancer research is key to ensuring a future without cancer.

Research funding from the National Institutes of Health (NIH) and, more specifically, the National Cancer Institute (NCI), made major contributions toward the strides taken against preventing and defeating cancer in the last decade. Even a small decrease in funding for these programs has the potential to derail this progress. AICR uses our voice and those of our researchers, both individually and as part of coalitions, to ensure that we continue on this path forward.

How We Are Taking Action

Coalitions Helping Us Achieve This Goal

  • One Voice Against Cancer
    In 2019, AICR joined One Voice Against Cancer (OVAC), a coalition of cancer-fighting organizations with the goal of increasing funding for federal cancer research programs.
    • In 2019, we signed onto OVAC’s letter urging Congress to provide at least $42.1 billion for NIH, with a proportional $6.4 billion increase for NCI for FY 2020. NIH was eventually funded at $41.46 billion, with NCI receiving $6.44 billion, a success for cancer research.
    • In 2020, we joined OVAC in asking for $44.7 billion for NIH in FY 2021, a $3 billion increase over 2020, with $6.9 billion for NCI.
    • In 2021, we partnered with other leading cancer and biomedical research organizations in requesting $46.4 billion for NIH in FY 2022, a $3.5 billion increase, including $7.6 billion for NCI.
    • We have also supported the provision of $10 billion in emergency relief funding to offset the impact of the COVID-19 pandemic on biomedical research.
    • AICR supports the establishment of an ARPA-H initiative focused on accelerating cancer research translation. AICR advocates that funding for ARPA-H not come at the expense of other appropriations for NIH or NCI, and that funds be used to address research across the spectrum from prevention to survivorship, including research on the impact of healthy lifestyles.
  • The Ad Hoc Group for Medical Research
    AICR joined the Ad Hoc Group for Medical Research in 2019 to help amplify our voice in advocating for increased federal funding for the NIH.
    • In 2019, we signed onto the Ad Hoc Group’s letter urging Congress to pass the FY2020 spending bill, funding the NIH and ending a Continuing Resolution that had left many uncertain about the future of biomedical research.
    • In 2020, we signed onto the Ad Hoc Group’s letter urging the allocation of emergency funding in the Senate HEALS Act to help offset challenges faced by researchers due to the Coronavirus pandemic.

Updated on September 23, 2021